Business Daily from THE HINDU group of publications
Sunday, Apr 05, 2009
ePaper | Mobile/PDA Version | Audio | Blogs
Business Daily from THE HINDU group of publications Sunday, Apr 05, 2009 ePaper | Mobile/PDA Version | Audio | Blogs |
|
|
|
|
|
Corporate
-
Regulatory Bodies & Rulings Zydus files new drug application with USFDA Our Bureau Ahmedabad, April 4Cadila Healthcare Ltd (Zydus Cadila) has announced the filing of the investigational new drug (IND) application for ZYT1 — a novel lipid lowering molecule with the US Federal Drug Administration (USFDA). Designed and developed at the Zydus Research Centre, ZYT1 is a novel, anti-dyslipidemic agent which may provide an alternative to statins or be an add-on to statin therapy, the company said here. Dyslipidemia is a clinical condition characterised by an elevation of cholesterol and/or triglycerides in the bloodstream. Over 80 per cent of patients with coronary heart disease, even those currently on medications, remain above the targeted levels for cholesterol. More Stories on : Regulatory Bodies & Rulings | Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2009, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|
